DarwinHealth Publication Reports Step-by-Step Protocol for its... - 12 September 2022 20:00

NEW YORK, Sept. 12, 2022 /PRNewswire-AsiaNet/ -- DarwinHealth, Inc., (www.DarwinHealth.com) a New York-based biotechnology and cancer drug discovery company announces the September 9, 2022 online publication in Current Protocols (Wiley Science) of their proprietary cancer drug discovery and vali...

  EpiVax Secures Additional Funding from FDA for Immunogenicity ... - 12 September 2022 19:59

PROVIDENCE, R.I., Sept. 12, 2022 /PRNewswire-AsiaNet/ -- EpiVax, Inc. ("EpiVax") is pleased to announce the award of a two-year, $2 million grant from the FDA's Office of Center for Drug Evaluation and Research (CDER) to validate a method for immunogenicity risk assessment of host cell proteins (HCP) fo...

  MASSIMO CALAFIORE APPOINTED AS NEW LIMACORPORATE CEO - 12 September 2022 19:00

VILLANOVA DI SAN DANIELE DEL FRIULI, UDINE, ITALY, Sep 12, 2022 /PRNewswire-AsiaNet/-- LimaCorporate, a leading global orthopedic manufacturer focused on digital innovation and patient-tailored devices, today announces that Massimo Calafiore has been appointed by the Board of Directors as the new Chief Executive Officer of the compa...

  FDI WORLD DENTAL FEDERATION LAUNCHES TOOLKIT ON HOW TO MAKE DE... - 12 September 2022 16:00

GENEVA, Sept. 12, 2022, /PRNewswire-AsiaNet/-- Dental practices can use the tools as a guide to make their work more environmentally sustainable and by tracking progress they can achieve recognition awards for their efforts. FDI World Dental Federation (FDI) today launched a Toolkit for S...

  First patient enrolled in Erectile Dysfunction prospective ran... - 12 September 2022 08:47

GENEVA, Switzerland, Sept. 10, 2022 /PRNewswire-AsiaNet/ -- An 82-year-old Taiwanese man has become the first patient to be enrolled in the initial Erectile Dysfunction (ED) randomized clinical trial (RCT) involving SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon. The PERFECT-SELU...

  ESMO 2022 - Great oaks grow from small acorns: oncology is com... - 10 September 2022 07:29

LONDON, Sep 9, 2022 /PRNewswire-AsiaNet/-- At ESMO 2022, 9-13 September, Paris, France, the premier cancer congress in Europe, which has gathered 28k participants from 167 countries, many discussions will be around sustainability, prevention and novel approaches which could soon become a r...

  ONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF P... - 08 September 2022 19:39

LAUSANNE, Switzerland, Sept. 8, 2022 /PRNewswire-AsiaNet/- - International health authorities, such as the WHO and the CDC are warning of the emerging danger of bacterial infections resistant to current antibiotics - The 2022 World Anti-Microbial Resistance (AMR) Congress in the greater Washingto...

  Non-invasive skin immune biomarker test helps predict developm... - 07 September 2022 09:01

MILAN, Sept. 6, 2022 /PRNewswire-AsiaNet/ -- Researchers have identified an immune biomarker in newborns that can predict the subsequent onset and severity of paediatric atopic eczema, a new study presented at the 31st European Academy of Dermatology and Venereology (EADV) Congress has shown...

  Hovione expands drug product offering with a new manufacturing... - 06 September 2022 23:31

LISBON, Portugal, September 6, 2022 /PRNewswire-AsiaNet/-- Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site...

  PharmaLex Strengthens Global Reach and Local Support with Offi... - 02 September 2022 13:10

FRANKFURT, Sept. 2, 2022/Medianet International-AsiaNet/-- PharmaLex Group, a leading provider of specialized services for the pharma, biotech and medtech industries worldwide, has announced the opening of a new branch in Beijing, China, giving global clients access to a team of regulatory experts in the ...